 Source: Shutterstock Poseida Therapeutics NASDAQ: PSTX stock is soaring on Wednesday after the clinical-stage biotechnology company announced a deal with Roche OTCMKTS: RHHBY . The agreement with Roche will have it working with Poseida Therapeutics to develop allogeneic CAR-T therapies directed to hematologic malignancies. 